- 13:46
South Korea Joins Signing Joint Statement on Strait of Hormuz to Contribute to International Efforts to Ensure Safe and Free Navigation -Foreign Ministry
13:05DR Reddy’s Exec- Collaborating With Two of India’s Leading Companies to Take Our Generic Semaglutide in Their Brand Name
13:05DR Reddy’s Exec- Aim to Launch Generic Semaglutide for Obesity in Next Few Months in India
11:54Hybe’s Bts Sold 3.98 Million Copies of Comeback Album “Arirang” on the First Day -Bighit
11:49Un Secretary General Says He’s Cooperating With Trump’s Board of Peace in Gaza - Politico
11:06Sun Pharma - Sematrinity Is Available in Two Dose Strengths - 2 Mg/1.5 Ml and 4 Mg/3 Ml
11:06Sun Pharma - Noveltreat Weekly Therapy Costs 900 Rupees-2,000 Rupees; Sematrinity 750 Rupees-1,300 Rupees
11:06Sun Pharma - Launches Its Semaglutide Injection Under Brand Names, Noveltreat and Sematrinity in India
11:04Mustang Energy Corp. Provides Update on Proposed Spin Out of Ford Lake Property by Way of Plan of Arrangement and Announces Share Distribution Record Date of March 26, 2026
10:42Zydus Lifesciences - Semaglutide Launched Under Semaglyn, Mashema, and Alterme Brands
10:42Zydus Lifesciences - Has Exclusive Rights to Reusable Pen Device for Semaglutide
10:42Zydus Lifesciences - Semaglutide Injection Priced at 2,200 Rupees per Month
10:06DR Reddy's : Aims to Introduce Generic Semaglutide in Several Countries as Part of Its Phase-1 Launch
10:06DR Reddy's - Each Obeda Pen Delivers 4 Weekly Doses; Cost to Patient 4,200 Rupees per Month
10:06DR Reddy's - Launches India's First Dcgi-Approved Semaglutide Injection Obeda for Type 2 Diabetes
